BDH2P1

Across TCGA pan-cancer cohorts, BDH2P1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated BDH2P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher BDH2P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated BDH2P1 expression acts as an unfavorable survival marker, although some lineages such as ACC and MESO show a favorable association.

ACC, MESO, and KIRC are the cancer types where BDH2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.769	0.306	<.001	121	view →
MESO	DFS	Median	All	0.456	0.273	.001	77	view →
KIRC	OS	Median	All	0.727	0.518	<.001	72	view →
READ	DFS	Median	All	0.942	0.535	<.001	60	view →
UVM	DFS	Quartile	II,III,IV	0.356	0.835	.006	47	view →
STAD	DFS	Median	IV	0.196	0.656	.008	36	view →
THCA	DFS	Quartile	All	0.931	0.721	.003	36	view →
KIRP	DFS	Median	All	0.927	0.622	.006	35	view →
LIHC	DFS	Median	III,IV	0.205	0.450	.001	32	view →
CHOL	DFS	Median	All	0.111	0.689	.001	21	view →
COAD	DFS	Tertile	II,III,IV	0.797	0.375	.002	16	view →
HNSC	OS	Median	IV	0.785	0.639	.005	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

BDH2P1–ACC (DFS)

Open the ACC breakdown →